Related Experiment Video
Updated: Dec 22, 2025

10:36
Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
Published on: November 21, 2025
145
Recognizing Inadequate Response in Patients With Major Depressive Disorder
The Journal of Clinical Psychiatry
|May 6, 2020
Summary
Recognizing inadequate antidepressant response is crucial for effective treatment. Differentiating it from treatment-resistant depression ensures patients receive appropriate care, avoiding prolonged inadequate therapies.
Area of Science:
- Psychiatry
- Clinical Psychology
- Pharmacology
Background:
- Distinguishing inadequate antidepressant response from treatment-resistant depression is vital for optimal patient outcomes.
- Current definitions for nonresponse and partial response vary, impacting clinical decision-making.
- Residual symptoms like low mood and anxiety characterize inadequate response.
Purpose of the Study:
- To clarify the definitions and characteristics of inadequate antidepressant response.
- To differentiate inadequate response from treatment-resistant depression.
- To identify factors contributing to inadequate treatment outcomes.
Main Methods:
- Review of existing literature on antidepressant treatment response and resistance.
- Analysis of diagnostic criteria and symptom profiles for inadequate response.
- Exploration of etiological factors contributing to poor treatment efficacy.
Main Results:
- Inadequate response is often defined by <50% improvement on rating scales.
- Key residual symptoms include low mood, anxiety, irritability, guilt, and somatic complaints.
- Contributing factors include incorrect dosage, insufficient treatment duration, poor patient adherence, and misdiagnosis.
Conclusions:
- Accurate identification of inadequate response is essential for timely therapeutic adjustments.
- Understanding contributing factors allows for targeted interventions to improve treatment success.
- Clearer definitions are needed to consistently manage antidepressant treatment challenges.
Related Concept Videos
Depressive Disorders: MDD and Dysthymia
459
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
459
Antidepressant Drugs: MAOIs and Other Agents
694
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
694
Depression: Overview
669
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
669
Psychosis: Goals of Pharmacotherapy
380
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
380
Depressive Disorders: Etiology
355
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
355
G-protein Coupled Receptors
131.1K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
131.1K

